Mobile version: On
Department of Neuroradiopharmaceuticals (FWPN)
- The main research focus of the Department of Neuroradiopharmaceuticals is the development and evaluation of radiolabelled ligands (radiotracers) in order to investigate brain functions in living organism. The application of the radiotracers in the brain provides images of transport, metabolic and neurotransmission processes on the molecular level. The methods used on humans to acquire such information is positron emission tomography (PET), the most sensitive and specific method available at present. Through integration of chemical/radiochemical, pharmaceutical/radiopharmaceutical, biochemical and radiopharmacological basic research, computational chemistry and with the aid of nuclear medicine diagnostic, a new approach in neuroscience will be made available. The foremost importance of this approach would be the monitoring of therapy for brain diseases.
- For more than a decade, a close cooperation with the Faculty of Medicine, University of Leipzig (in particular the Departments of Nuclear Medicine and Neurology and the Paul-Flechsig Institute of Brain Research), in the field of radiotracer development for neuroimaging of brain diseases exists. These research projects are integrated in the Top Level Research Areas Molecular and Cellular Communication and Brain Dynamics at the University of Leipzig.